In addition, in the study by Numoto et al., it was determined that the RASSF1A methylation rate was higher in synovial sarcoma patients compared to other soft tissue sarcomas. Additionally, RASSF1A was shown to be downregulated due to promoter methylation [42]. Here, RASSF1 is linked to soft tissue sarcoma.